CN Patent

CN110637027B — 包含药代动力学增强子的修饰的松弛素多肽及其用途

Assigned to Bristol Myers Squibb Co · Expires 2024-08-30 · 2y expired

What this patent protects

本公开总体上涉及包含与药代动力学增强子连接的非天然编码氨基酸的修饰的松弛素多肽，如修饰的人松弛素2多肽，以及这样的多肽的治疗用途，例如用于治疗心血管病症(例如心力衰竭)和/或与纤维化相关的病症。

USPTO Abstract

本公开总体上涉及包含与药代动力学增强子连接的非天然编码氨基酸的修饰的松弛素多肽，如修饰的人松弛素2多肽，以及这样的多肽的治疗用途，例如用于治疗心血管病症(例如心力衰竭)和/或与纤维化相关的病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN110637027B
Jurisdiction
CN
Classification
—
Expires
2024-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.